Skip to content

Clinical and Hemodynamic Outcomes of Surgical Repair of Tricuspid Valve Regurgitation in Adults: A Randomized Clinical Study

Clinical and Hemodynamic Outcomes of Surgical Repair of Tricuspid Valve Regurgitation in Adults: A Randomized Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202311528755058
Enrollment
75
Registered
2023-11-09
Start date
2017-09-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System Surgery

Interventions

Tricuspid Valve annuloplasty Devega repair
Tricuspid segmental Annuloplasty
Tricuspid valve annuloplasty using other techniques

Sponsors

Mansoura University Faculty of Medicine
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Eligible were (75) consecutive adult patients who will underwent tricuspid valve surgery with or without concomitant cardiac procedures for heart disease at our institution were be included and divided into three randomized groups: two groups of semicircular Annuloplasty techniques, plus a third group using other techniques. The decision in favor of or against tricuspid valve repair was at the discretion of the institutional heart team based on the operating surgeons’ and the cardiologist’s findings with special concern regarding the valve anatomy. ? Adult Patient with tricuspid regurgitation. ? Redo cardiac patients except previous tricuspid repair. ? Patients with poor ventricular functions and pulmonary hypertension will be also included.

Exclusion criteria

Exclusion criteria: ? Patients with infective pathology. ? Redo tricuspid valve repairs. ? Pregnancy ?Refusing the enrollment in the study.

Design outcomes

Primary

MeasureTime frame
Primary Outcome measure was intraoperative and early postoperative include Repair failure measured by the degree of tricuspid regurgitation by echocardiography (None – mild – moderate – Severe).

Secondary

MeasureTime frame
Secondary outcomes will include: Need for Pacemaker placement, Hospital morbidity and Mortality at 30 days, Cross clamp and cardiopulmonary bypass time, Ventilation time in hours, ICU stay in days, Hospital stay in days. Post-operative echo will be performed to determine the success of the repair and Post-operative patient symptoms will be reassessed regarding dyspnea according to NYHA class. Postoperative complications anticipated will include: Major Adverse Cardiac Events (MACEs), respiratory complications, wound infections, Need for surgical re-exploration, Arrhythmias, and Readmission within 30 days.

Countries

Egypt

Contacts

Public ContactHatem Beshir

Department of Cardiothoracic Surgery Faculty of Medicine Mansoura University Egypt

Hatem.beshir@alexmed.edu.eg+201003711756

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026